Iol-KT Eye Drop is a combination ophthalmic solution containing Ketorolac 0.4% w/v and Olopatadine 0.1% w/v, formulated for the management of ocular inflammation and allergic conjunctivitis. Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and edema in ocular tissues. Olopatadine, a selective histamine H1 receptor antagonist with mast cell stabilizing properties, effectively alleviates symptoms associated with allergic conjunctivitis such as itching, redness, and swelling by preventing the release of histamine and other inflammatory mediators. The dual-action mechanism of Iol-KT Eye Drop provides symptomatic relief in conditions characterized by both inflammatory and allergic components, including postoperative inflammation, seasonal allergic conjunctivitis, and vernal keratoconjunctivitis. It is typically administered as one or two drops in the affected eye(s) two to three times daily or as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to any component of the formulation. The product should not be used in active ocular infections or in individuals with known hypersensitivity to NSAIDs or antihistamines. Proper administration technique and adherence to prescribed dosage are essential to maximize therapeutic outcomes and minimize potential adverse effects.